FIBROBLASTY KOZhI ZARODYShEY I IKh UChASTIE V REGENERATsII KOZhNYKh RAN I SKELETNYKh MYShTs

O N Sheveleva , S G Ramazanova , O V Payushina , N N Butorina

Medical academic journal ›› 2016, Vol. 16 ›› Issue (4) : 244 -245.

PDF
Medical academic journal ›› 2016, Vol. 16 ›› Issue (4) :244 -245. DOI: 10.17816/MAJ164244-245
Articles
brief-report

FIBROBLASTY KOZhI ZARODYShEY I IKh UChASTIE V REGENERATsII KOZhNYKh RAN I SKELETNYKh MYShTs

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
O N Sheveleva, S G Ramazanova, O V Payushina, N N Butorina. FIBROBLASTY KOZhI ZARODYShEY I IKh UChASTIE V REGENERATsII KOZhNYKh RAN I SKELETNYKh MYShTs. Medical academic journal, 2016, 16(4): 244-245 DOI:10.17816/MAJ164244-245

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement / Dominici M., Le Blanc K., Mueller.I, Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop Dj., Horwitz E. // Cytotherapy.- 2006.- Vol. 8 (4).- P. 315-317.

[2]

Treatment of inflammatory diseases with mesenchymal stem cells / Newman R. E., Yoo D., LeRoux M. A., Danilkovitch-Miagkova A. // Inflamm Allergy Drug Targets.- 2009.- Vol. 8 (2).- P. 110-123.

[3]

Muscle regeneration by bone marrow-derived myogenic progenitors / Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., Mavilio F. // Science.- 1998.- Vol. 279 (5356) - P. 1528-1530.

[4]

Caplan A. I. Why are MSCs therapeutic? New data: new insight // J. Pathol.- 2009.- Vol. 217 (2).- P. 318-324.

RIGHTS & PERMISSIONS

Sheveleva O.N., Ramazanova S.G., Payushina O.V., Butorina N.N.

PDF

39

Accesses

0

Citation

Detail

Sections
Recommended

/